日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/06/18 | 7,550 | 7,560 | 7,240 | 7,310 | -220 | -2.9% | 256,600 |
| 2018/06/15 | 7,690 | 7,700 | 7,520 | 7,530 | -110 | -1.4% | 305,100 |
| 2018/06/14 | 7,570 | 7,670 | 7,520 | 7,640 | +30 | +0.4% | 206,000 |
| 2018/06/13 | 7,570 | 7,690 | 7,500 | 7,610 | +110 | +1.5% | 202,000 |
| 2018/06/12 | 7,490 | 7,580 | 7,430 | 7,500 | +10 | +0.1% | 209,300 |
| 2018/06/11 | 7,470 | 7,560 | 7,440 | 7,490 | +30 | +0.4% | 150,400 |
| 2018/06/08 | 7,470 | 7,510 | 7,410 | 7,460 | -150 | -2% | 301,700 |
| 2018/06/07 | 7,660 | 7,700 | 7,550 | 7,610 | -50 | -0.7% | 161,300 |
| 2018/06/06 | 7,730 | 7,750 | 7,630 | 7,660 | -110 | -1.4% | 178,400 |
| 2018/06/05 | 7,890 | 7,950 | 7,700 | 7,770 | -230 | -2.9% | 145,900 |
| 2018/06/04 | 7,870 | 8,020 | 7,810 | 8,000 | +280 | +3.6% | 230,300 |
| 2018/06/01 | 7,790 | 7,850 | 7,690 | 7,720 | -90 | -1.2% | 164,200 |
| 2018/05/31 | 7,600 | 7,870 | 7,530 | 7,810 | +210 | +2.8% | 399,100 |
| 2018/05/30 | 7,650 | 7,680 | 7,550 | 7,600 | -150 | -1.9% | 187,500 |
| 2018/05/29 | 7,740 | 7,890 | 7,680 | 7,750 | -60 | -0.8% | 151,000 |
| 2018/05/28 | 7,730 | 7,920 | 7,730 | 7,810 | +20 | +0.3% | 133,500 |
| 2018/05/25 | 7,790 | 7,840 | 7,760 | 7,790 | -20 | -0.3% | 158,700 |
| 2018/05/24 | 7,880 | 7,890 | 7,780 | 7,810 | -80 | -1% | 189,000 |
| 2018/05/23 | 7,880 | 7,950 | 7,810 | 7,890 | +10 | +0.1% | 180,600 |
| 2018/05/22 | 7,800 | 7,920 | 7,790 | 7,880 | +100 | +1.3% | 229,000 |
| 2018/05/21 | 7,890 | 7,900 | 7,740 | 7,780 | -150 | -1.9% | 131,000 |
| 2018/05/18 | 7,880 | 7,970 | 7,800 | 7,930 | +60 | +0.8% | 167,200 |
| 2018/05/17 | 7,760 | 7,900 | 7,740 | 7,870 | +200 | +2.6% | 225,300 |
| 2018/05/16 | 7,780 | 7,910 | 7,630 | 7,670 | -100 | -1.3% | 285,600 |
| 2018/05/15 | 7,990 | 8,090 | 7,750 | 7,770 | -120 | -1.5% | 337,600 |
| 2018/05/14 | 8,190 | 8,220 | 7,850 | 7,890 | -390 | -4.7% | 271,700 |
| 2018/05/11 | 7,940 | 8,360 | 7,940 | 8,280 | +450 | +5.7% | 490,600 |
| 2018/05/10 | 7,560 | 7,880 | 7,410 | 7,830 | +120 | +1.6% | 579,700 |
| 2018/05/09 | 7,670 | 7,730 | 7,600 | 7,710 | +50 | +0.7% | 276,800 |
| 2018/05/08 | 7,770 | 7,870 | 7,630 | 7,660 | -140 | -1.8% | 258,000 |
| 2018/05/07 | 7,840 | 7,930 | 7,690 | 7,800 | +20 | +0.3% | 216,200 |
| 2018/05/02 | 7,710 | 7,820 | 7,560 | 7,780 | +50 | +0.6% | 418,500 |
| 2018/05/01 | 8,060 | 8,060 | 7,670 | 7,730 | -430 | -5.3% | 412,600 |
| 2018/04/27 | 7,990 | 8,170 | 7,920 | 8,160 | +320 | +4.1% | 320,500 |
| 2018/04/26 | 7,790 | 7,870 | 7,760 | 7,840 | -190 | -2.4% | 370,300 |
| 2018/04/25 | 7,880 | 8,050 | 7,870 | 8,030 | +180 | +2.3% | 374,600 |
| 2018/04/24 | 8,240 | 8,260 | 7,810 | 7,850 | -390 | -4.7% | 498,000 |
| 2018/04/23 | 8,340 | 8,350 | 8,090 | 8,240 | -240 | -2.8% | 287,100 |
| 2018/04/20 | 8,090 | 8,490 | 8,080 | 8,480 | +390 | +4.8% | 600,000 |
| 2018/04/19 | 8,040 | 8,250 | 7,970 | 8,090 | +280 | +3.6% | 548,000 |
| 2018/04/18 | 7,560 | 7,840 | 7,430 | 7,810 | +250 | +3.3% | 320,200 |
| 2018/04/17 | 7,540 | 7,630 | 7,520 | 7,560 | -10 | -0.1% | 183,700 |
| 2018/04/16 | 7,270 | 7,580 | 7,250 | 7,570 | +370 | +5.1% | 279,300 |
| 2018/04/13 | 7,350 | 7,390 | 7,140 | 7,200 | -90 | -1.2% | 208,800 |
| 2018/04/12 | 7,210 | 7,330 | 7,210 | 7,290 | +150 | +2.1% | 225,800 |
| 2018/04/11 | 7,330 | 7,350 | 7,120 | 7,140 | -270 | -3.6% | 328,300 |
| 2018/04/10 | 7,600 | 7,600 | 7,390 | 7,410 | -100 | -1.3% | 206,700 |
| 2018/04/09 | 7,430 | 7,560 | 7,390 | 7,510 | +80 | +1.1% | 240,300 |
| 2018/04/06 | 7,490 | 7,570 | 7,410 | 7,430 | -70 | -0.9% | 246,000 |
| 2018/04/05 | 7,350 | 7,540 | 7,330 | 7,500 | +230 | +3.2% | 261,000 |
1701～
1750
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
